Bill > S2372

This bill, known as the 340B PATIENTS Act of 2025, aims to clarify and strengthen the 340B drug discount program, which allows certain healthcare providers to purchase prescription drugs at reduced prices. The bill reinforces that drug manufacturers must offer discounted pricing to covered entities (like hospitals and clinics) regardless of how or where the drugs are dispensed, including through contract pharmacies. It specifically prohibits manufacturers from placing unreasonable conditions on drug purchases, such as limiting drug delivery mechanisms, requiring excessive compliance reporting, or discouraging participation in the program. The legislation also establishes penalties for manufacturers who violate these requirements, with potential civil monetary penalties of up to $2 million per day for intentional violations. The bill's key purposes are to ensure that healthcare providers can continue to use contract pharmacies to extend their reach, access critical specialty drugs, and stretch their resources to provide more comprehensive patient care. By codifying these protections, the bill seeks to preserve the original intent of the 340B program: helping healthcare providers serving vulnerable communities deliver more affordable and accessible healthcare services.

Health and Social Services

https://www.congress.gov/bill/119th-congress/senate-bill/2372/all-info